Online Only Articles

Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors

Department of Experimental Immunology, Academic Medical Center, University of Amsterdam;Department of Hematology, Academic Medical Center, University of Amsterdam
Department of Experimental Immunology, Academic Medical Center, University of Amsterdam;Department of Hematology, Academic Medical Center, University of Amsterdam
Department of Experimental Immunology, Academic Medical Center, University of Amsterdam
Department of Experimental Immunology, Academic Medical Center, University of Amsterdam
AIMM Therapeutics, Amsterdam
Department of Hematology, Academic Medical Center, University of Amsterdam;Lymphoma and Myeloma Center Amsterdam, LYMMCARE, The Netherlands
Department of Hematology, Academic Medical Center, University of Amsterdam;Lymphoma and Myeloma Center Amsterdam, LYMMCARE, The Netherlands
Department of Experimental Immunology, Academic Medical Center, University of Amsterdam;Lymphoma and Myeloma Center Amsterdam, LYMMCARE, The Netherlands
Vol. 100 No. 8 (2015): August, 2015 https://doi.org/10.3324/haematol.2015.124560